A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia on Stable Lipid lowering Therapy.


2015 - 2016

Tipo de financiación


Investigador principal

Francisco Javier Nóvoa

Investigadores participantes

AM Wägner
Rosa M Sánchez

Entidades financiadoras

Aegerion Pharmaceuticals